Presentation · Oct 2026 · PDF
Science
Explore conditions, clinical trials, and the latest research.
These pages contain non-exhaustive scientific information about uses of products that have not yet been approved by regulatory authorities, as their efficacy and safety for these uses have not yet been established. The information is provided for educational and scientific exchange purposes, and does not suggest products should be used in a manner not consistent with their respective label approved by the regulatory authorities, which may differ by geography. Any publication reflects the state of knowledge at the time it was published. The information is not medical advice and cannot replace the independent medical judgement of a healthcare professional.
Presentation · Oct 2026 · PDF
BBIO-Encaleret-ASBMR-2026-CALIBRATE SymptomResponse-Ing
Presentation · Oct 2026 · PDF
BBIO-Encaleret-ASBMR-2026-CALIBRATE Bone response-Imel
Presentation · Oct 2026 · PDF
BBIO-Infigratinib-ASBMR-2026-FGFR1
Presentation · Oct 2026 · PDF
BBIO-Acoramidis-HFSA-2026-ATTRibute-CM, OWHF (aka ODI)-Judge
Presentation · Oct 2026 · PDF
BBIO-Acoramidis-HFSA-2026-eGFR rx arm median and recurrent CVHACM-Masri-Oral
Presentation · Oct 2026 · PDF
BBIO-Acoramidis-HFSA-2026-KCCQ-OS pre and post CVH-Masri
Presentation · Oct 2026 · PDF
BBIO-Acoramidis-HFSA-2026-RW CE vs Taf (Epic COSMOS EHR)-Lanfear
Presentation · Oct 2026 · PDF
BBIO-Acoramidis-HFSA-2026-LB sTTR NT-proBNP Ratio and Outcomes-Myhre
Presentation · Oct 2026 · PDF